Superpower Launches Peptide Library Mapping 152 Peptides by Body Location
Superpower has released its Peptide Library, mapping 152 peptides spanning approved drugs and compounds still in trials, with physician-reviewed pages covering
On October 27, 2026, Superpower announced the Superpower Peptide Library, mapping 152 peptides from approved drugs to compounds still in trials and sorting them by where they act.
Image source: @superpower via X
The library provides a dedicated, fully cited page for each peptide, reviewed by a physician and covering evidence strength, FDA status, mechanism of action, and findings from studies in humans.
Highlighting Regulatory Status and Preclinical Limits
The entries distinguish peptides by regulatory status and evidence strength.
Superpower contrasts FDA-approved semaglutide with BPC-157, which is not FDA-approved and is frequently discussed for recovery and repair, noting that 35 of 36 studies in a 2025 review were conducted in animals or the laboratory.
- Approved Drugs vs. Unapproved Compounds: Transparently discloses FDA approval status alongside actual human clinical data availability.
- Evidence Strength Evaluation: Summarizes evidence strength and describes each peptide's mechanism of action.
Enhancing Healthcare Data Transparency
Superpower presents the library as a way to review the science before accepting hype. Users can examine cited evidence, FDA status, mechanisms of action, and findings from studies in humans.
Sources
- Superpower Official X (@superpower): Superpower Peptide Library Announcement